The Weight Is Over: Capitalising on the Booming Weight Loss Drug Industry | Nucleus Investment Insights
In this week’s podcast, Nucleus Wealth’s Chief Investment Officer Damien Klassen, Senior Investment Analyst Radek Zeleny, and Head of Advice Samuel Kerr, delve into the fast-growing market of weight loss drugs, exploring the latest trends, breakthroughs, and market dynamics. We provide an in-depth ...
By Samuel Kerr